These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 19559599)
1. Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. Lee JE; Saphire EO Curr Opin Struct Biol; 2009 Aug; 19(4):408-17. PubMed ID: 19559599 [TBL] [Abstract][Full Text] [Related]
2. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622 [TBL] [Abstract][Full Text] [Related]
3. Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope. West BR; Moyer CL; King LB; Fusco ML; Milligan JC; Hui S; Saphire EO mBio; 2018 Sep; 9(5):. PubMed ID: 30206174 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for differential neutralization of ebolaviruses. Bale S; Dias JM; Fusco ML; Hashiguchi T; Wong AC; Liu T; Keuhne AI; Li S; Woods VL; Chandran K; Dye JM; Saphire EO Viruses; 2012 Apr; 4(4):447-70. PubMed ID: 22590681 [TBL] [Abstract][Full Text] [Related]
5. Structural Transition and Antibody Binding of EBOV GP and ZIKV E Proteins from Pre-Fusion to Fusion-Initiation State. Lappala A; Nishima W; Miner J; Fenimore P; Fischer W; Hraber P; Zhang M; McMahon B; Tung CS Biomolecules; 2018 May; 8(2):. PubMed ID: 29748487 [TBL] [Abstract][Full Text] [Related]
6. A heterologous prime-boost Ebola virus vaccine regimen induces durable neutralizing antibody response and prevents Ebola virus-like particle entry in mice. Chen T; Li D; Song Y; Yang X; Liu Q; Jin X; Zhou D; Huang Z Antiviral Res; 2017 Sep; 145():54-59. PubMed ID: 28733113 [TBL] [Abstract][Full Text] [Related]
7. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. Hood CL; Abraham J; Boyington JC; Leung K; Kwong PD; Nabel GJ J Virol; 2010 Mar; 84(6):2972-82. PubMed ID: 20053739 [TBL] [Abstract][Full Text] [Related]
8. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies. Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579 [TBL] [Abstract][Full Text] [Related]
9. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655 [TBL] [Abstract][Full Text] [Related]
10. [Research progress on ebola virus glycoprotein]. Ding GY; Wang ZY; Gao L; Jiang BF Bing Du Xue Bao; 2013 Mar; 29(2):233-7. PubMed ID: 23757858 [TBL] [Abstract][Full Text] [Related]